Chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who were admitted to our hospital for evaluation and education of chronic kidney disease since June 2009 and gave written-informed consent. 2) Additional patients who were admitted to our hospital for evaluation and education of chronic kidney disease between January 2005 and May 2009 and gave informed consent by disclosure of information.
Exclusion criteria
Exclusion criteria: 1) Patient who did not give informed consent. 2) Patients under poor condition who were accompanied by acute phase of infectious, cardiovascular, respiratory, digestive system, and liver diseases. 3) Patients who were judged as inappropriate by attending physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of cardiovascular diseases and association of clinical parameters with cardiovascular diseases and subsequent cardiovascular diseases. | — |
Secondary
| Measure | Time frame |
|---|---|
| Association of clinical parameters with all-cause and cardiovascular mortality, and adverse renal outcomes (doubling of serum creatinine, end-stage renal disease requiring dialysis and slope of estimated glomerular filtration rate). Relationships among clinical characteristics at baseline on a cross-sectional analysis. | — |
Countries
Japan
Contacts
National Hospital Organization Kyushu Medical Center Nephrology